Published :
Tables : 48
Figures : 45
Category : Healthcare
No. of Pages : 221
Report Code : HC-1263
Dental Biomaterials Market is poised to value USD 13062.6 million by 2028 end at a CAGR of 6.2% during the forecast period 2022 to 2028. The dental biomaterials are synthetic or biological products usually used for restoring periodontal structures and tooth-supporting structures like soft tissues and bones. Bone graft membranes, soft tissue products for regeneration and materials are commonly used for procedures of oral regeneration. A rising number of implant procedures across the world and an increase in the geriatric patient population with some or no teeth have resulted in the increased requirement of bone graft materials. An increase in dental tourism in developing nations and a rise in the number of dental diseases are projected to escalate the market growth in the upcoming years. The global dental biomaterials market is bifurcated based on application, product, end-user and region. Based on the product, the market is categorised into dental membranes, soft tissue regeneration products and bone graft materials. The market segment that predicted to hold a leading market share over the forecast period is bone graft material segment and it is due to an increase in the utilization of xenografts, synthetic grafts and allografts in periodontal defects treatment. On the basis of the application, the market is segmented into periodontology, implantology, and others. In 2017, implantology accounted for a major market share, due to a rising number of implant-related procedures worldwide. Based on the end-user, the market is categorised into dental clinics and hospitals. The hospitals segment is predicted to showcase substantial proliferation in the upcoming years. Key market players included in the global dental biomaterials industry are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings Inc., Danaher Corp., Dentsply Sirona Inc., 3M Company, Royal DSM, Carpenter Technology Corp., Kuraray CO.Ltd., Medtronic Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corp., Keystone Dental Ltd. Datum Dental Ltd., Bego Medical GmbH, Cam Bioceramics B.V. Dental Biomaterials Market Segmentation: By Type • Metallic Biomaterials o Titanium o Stainless Steel o Chromium Alloys o Other Metallic Biomaterials • Ceramic Biomaterials • Polymeric Biomaterials • Metal-Ceramic Biomaterials • Natural Biomaterials By Application • Implantology • Prosthodontist • Orthodontist • Others By End User • Dental Product Manufacturers • Dental Laboratories • Dental Hospitals and Clinics • Dental Academics and Research Institutes By Region • Europe • North America • Asia Pacific • Latin America • Middle East & Africa FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global dental biomaterials market by type, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The dental biomaterials are synthetic or biological products usually used for restoring periodontal structures and tooth-supporting structures like soft tissues and bones. Bone graft membranes, soft tissue products for regeneration and materials are commonly used for procedures of oral regeneration. A rising number of implant procedures across the world and an increase in the geriatric patient population with some or no teeth have resulted in the increased requirement of bone graft materials. An increase in dental tourism in developing nations and a rise in the number of dental diseases are projected to escalate the market growth in the upcoming years.
The global dental biomaterials market is bifurcated based on application, product, end-user and region. Based on the product, the market is categorised into dental membranes, soft tissue regeneration products and bone graft materials. The market segment that predicted to hold a leading market share over the forecast period is bone graft material segment and it is due to an increase in the utilization of xenografts, synthetic grafts and allografts in periodontal defects treatment. On the basis of the application, the market is segmented into periodontology, implantology, and others. In 2017, implantology accounted for a major market share, due to a rising number of implant-related procedures worldwide. Based on the end-user, the market is categorised into dental clinics and hospitals. The hospitals segment is predicted to showcase substantial proliferation in the upcoming years.
Key market players included in the global dental biomaterials industry are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings Inc., Danaher Corp., Dentsply Sirona Inc., 3M Company, Royal DSM, Carpenter Technology Corp., Kuraray CO.Ltd., Medtronic Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corp., Keystone Dental Ltd. Datum Dental Ltd., Bego Medical GmbH, Cam Bioceramics B.V.
Dental Biomaterials Market Segmentation:
By Type
• Metallic Biomaterials o Titanium o Stainless Steel o Chromium Alloys o Other Metallic Biomaterials • Ceramic Biomaterials • Polymeric Biomaterials • Metal-Ceramic Biomaterials • Natural Biomaterials
By Application
• Implantology • Prosthodontist • Orthodontist • Others
By End User
• Dental Product Manufacturers • Dental Laboratories • Dental Hospitals and Clinics • Dental Academics and Research Institutes
By Region • Europe • North America • Asia Pacific • Latin America • Middle East & Africa
FutureWise Key Takeaways
• Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global dental biomaterials market by type, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Dental Biomaterials Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Dental Biomaterials Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Dental Biomaterials Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Dental Biomaterials Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Metallic Biomaterials 7.1.1. Titanium 7.1.2. Stainless Steel 7.1.3. Chromium Alloys 7.1.4. Other Metallic Biomaterials 7.2. Ceramic Biomaterial 7.3. Polymeric Biomaterials 7.4. Metal-Ceramic Biomaterials 7.5. Natural Biomaterials 8. Dental Biomaterials Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Implantology 8.2. Prosthodontist 8.3. Orthodontist 8.4. Others 9. Dental Biomaterials Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Dental Product Manufacturers 9.2. Dental Laboratories 9.3. Dental Hospitals and Clinics 9.4. Dental Academics and Research Institutes 10. North America Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Straumann Holding AG 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Geistlich Pharma AG 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Zimmer Biomet Holdings Inc 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Danaher Corp. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Dentsply Sirona Inc. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. 3M Company 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Royal DSM 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Carpenter Technology Corp. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Kuraray CO.Ltd. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Medtronic Ltd. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Henry Schein Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Mitsui Chemicals Inc. 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Victrex PLC 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Ivoclar Vivadent AG 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.GC Corp. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Keystone Dental Ltd. 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Datum Dental Ltd. 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Bego Medical GmbH 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19.Cam Bioceramics B.V. 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Dental Biomaterials Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Dental Biomaterials Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Dental Biomaterials Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Dental Biomaterials Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Metallic Biomaterials 7.1.1. Titanium 7.1.2. Stainless Steel 7.1.3. Chromium Alloys 7.1.4. Other Metallic Biomaterials 7.2. Ceramic Biomaterial 7.3. Polymeric Biomaterials 7.4. Metal-Ceramic Biomaterials 7.5. Natural Biomaterials
8. Dental Biomaterials Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Implantology 8.2. Prosthodontist 8.3. Orthodontist 8.4. Others
9. Dental Biomaterials Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Dental Product Manufacturers 9.2. Dental Laboratories 9.3. Dental Hospitals and Clinics 9.4. Dental Academics and Research Institutes
10. North America Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Dental Biomaterials Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Straumann Holding AG 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Geistlich Pharma AG 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Zimmer Biomet Holdings Inc 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Danaher Corp. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Dentsply Sirona Inc. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. 3M Company 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Royal DSM 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Carpenter Technology Corp. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Kuraray CO.Ltd. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Medtronic Ltd. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Henry Schein Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Mitsui Chemicals Inc. 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Victrex PLC 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Ivoclar Vivadent AG 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.GC Corp. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Keystone Dental Ltd. 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Datum Dental Ltd. 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18.Bego Medical GmbH 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19.Cam Bioceramics B.V. 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics